Viewing Study NCT00673556


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-07 @ 9:04 PM
Study NCT ID: NCT00673556
Status: COMPLETED
Last Update Posted: 2014-08-26
First Post: 2008-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate
Sponsor: Astellas Pharma Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Plaque Psoriasis View
None Alefacept View